ZA200800567B - Compounds for treatment of lipase-mediated diseases - Google Patents
Compounds for treatment of lipase-mediated diseasesInfo
- Publication number
- ZA200800567B ZA200800567B ZA200800567A ZA200800567A ZA200800567B ZA 200800567 B ZA200800567 B ZA 200800567B ZA 200800567 A ZA200800567 A ZA 200800567A ZA 200800567 A ZA200800567 A ZA 200800567A ZA 200800567 B ZA200800567 B ZA 200800567B
- Authority
- ZA
- South Africa
- Prior art keywords
- lipase
- compounds
- treatment
- mediated diseases
- mediated
- Prior art date
Links
- 102000004882 Lipase Human genes 0.000 title 1
- 108090001060 Lipase Proteins 0.000 title 1
- 239000004367 Lipase Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 235000019421 lipase Nutrition 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/04—Benzoquinones, i.e. C6H4O2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN864MU2005 | 2005-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200800567B true ZA200800567B (en) | 2008-11-26 |
Family
ID=36121552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200800567A ZA200800567B (en) | 2005-07-21 | 2008-01-18 | Compounds for treatment of lipase-mediated diseases |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1937622A1 (en) |
| JP (1) | JP2009505953A (en) |
| KR (1) | KR100928954B1 (en) |
| CN (1) | CN101228108A (en) |
| AU (1) | AU2005334672A1 (en) |
| BR (1) | BRPI0520515A2 (en) |
| CA (1) | CA2614585A1 (en) |
| IL (1) | IL188894A0 (en) |
| NZ (1) | NZ565878A (en) |
| RU (1) | RU2420513C2 (en) |
| WO (1) | WO2007010546A1 (en) |
| ZA (1) | ZA200800567B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| SG11201507105RA (en) * | 2013-03-14 | 2015-10-29 | Shionogi & Co | Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase |
| JP2016534049A (en) * | 2013-10-08 | 2016-11-04 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションTemple University−Of The Commonwealth System Of Higher Education | Functionalized furan-2-sulfonamide showing endothelial lipase inhibition |
| EP3197886B1 (en) | 2014-09-26 | 2023-01-04 | Shifa Biomedical Corporation | Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7510536A (en) * | 1975-09-05 | 1977-03-08 | Council Scient Ind Res | Salts of embelin with primary amines |
| DE2540282A1 (en) * | 1975-09-10 | 1977-03-24 | Council Scient Ind Res | Salts of embelin with primary amines - used as analgesics, tranquillisers, antiinflammatories, anthelmintics, hypotensives and antipyretics |
| US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
-
2005
- 2005-09-19 EP EP05823794A patent/EP1937622A1/en not_active Withdrawn
- 2005-09-19 BR BRPI0520515-8A patent/BRPI0520515A2/en not_active IP Right Cessation
- 2005-09-19 AU AU2005334672A patent/AU2005334672A1/en not_active Abandoned
- 2005-09-19 CN CNA2005800511311A patent/CN101228108A/en active Pending
- 2005-09-19 WO PCT/IN2005/000318 patent/WO2007010546A1/en not_active Ceased
- 2005-09-19 KR KR1020087001911A patent/KR100928954B1/en not_active Expired - Fee Related
- 2005-09-19 CA CA002614585A patent/CA2614585A1/en not_active Abandoned
- 2005-09-19 JP JP2008522176A patent/JP2009505953A/en active Pending
- 2005-09-19 RU RU2008106628/04A patent/RU2420513C2/en not_active IP Right Cessation
- 2005-09-19 NZ NZ565878A patent/NZ565878A/en not_active IP Right Cessation
-
2008
- 2008-01-18 ZA ZA200800567A patent/ZA200800567B/en unknown
- 2008-01-20 IL IL188894A patent/IL188894A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007010546A1 (en) | 2007-01-25 |
| CN101228108A (en) | 2008-07-23 |
| CA2614585A1 (en) | 2007-01-25 |
| KR20080030044A (en) | 2008-04-03 |
| IL188894A0 (en) | 2008-04-13 |
| RU2420513C2 (en) | 2011-06-10 |
| BRPI0520515A2 (en) | 2009-05-12 |
| KR100928954B1 (en) | 2009-11-30 |
| NZ565878A (en) | 2010-04-30 |
| JP2009505953A (en) | 2009-02-12 |
| RU2008106628A (en) | 2009-08-27 |
| AU2005334672A1 (en) | 2007-01-25 |
| EP1937622A1 (en) | 2008-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL194076A0 (en) | Imidazolothiazole compounds for the treatment of disease | |
| IL195571A0 (en) | Compounds for the treatment of periodontal disease | |
| IL187739A0 (en) | New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases | |
| IL188746A0 (en) | Treatment of cancer | |
| IL186578A0 (en) | Compositions for treatment of neovascularization diseases | |
| SI2044111T1 (en) | Targeting complement factor h for treatment of diseases | |
| EP2004204A4 (en) | Treatment of neurodegenerative diseases | |
| IL190779A0 (en) | Compositions for treatment of eye diseases | |
| IL187715A0 (en) | Use of phenylsemicarbazones for seed treatment | |
| IL186904A0 (en) | Novel compounds for treating inflammatory diseases | |
| IL188894A0 (en) | Compounds for treatment of lipase-mediated diseases | |
| GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
| GB0518508D0 (en) | Treatment of waste | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| EP1867640A4 (en) | Agent for treatment of solid tumor | |
| GB0605715D0 (en) | Treatment of laminitis | |
| ZA200707592B (en) | Novel compounds for treating inflammatory diseases | |
| IL190182A0 (en) | 2-aminoalcohols for the treatment of neurodegenerative diseases | |
| GB0520067D0 (en) | Treatment of cancer | |
| ZA200800393B (en) | Use of phenylsemicarbazones for seed treatment | |
| HK1112620A (en) | Compounds for treatment of lipase-mediated diseases | |
| ZA200904660B (en) | Treatment of IL-1-Beta related diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| EP1846013A4 (en) | Treatment of skin diseases | |
| HUP0500947A2 (en) | Composition for treatment of paradontosis |